A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema
Clinical trial NCT04432831 · COMPLETED
Trial details
- NCT number
- NCT04432831
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-05
- Primary completion
- 2023-10-11
- Enrollment
- 1479
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.